• SENSEX 81,748.72
    -510.52 (--0.62%)
  • BANKNIFTY 56,828.80
    -340.15 (--0.59%)
  • AWL Agri Busine.
    267.55 231.55(%)
  • Le Travenues
    226.20 214.90(%)
  • Waaree Renewab.
    1,239.50 2,074.95(%)
  • Axis Bank
    1,073.95 934.00(%)
  • Magellanic Cloud
    81.55 42.60(%)
  • Enviro Infra
    306.30 392.00(%)
  • HDFC AMC
    5,625.00 5,547.50(%)
  • L&T Finance Ltd
    206.75 212.75(%)
  • JP Power Ven.
    23.48 27.62(%)
  • Infosys
    1,599.00 2,006.80(%)
  • Jio Financial
    313.80 198.60(%)
  • HDFC Bank
    1,965.90 1,588.50(%)
  • Garuda Cons
    179.80 153.50(%)
  • Inventurus Knowl
    1,600.00 1,226.15(%)
  • Waaree Energies
    3,125.00 1,808.65(%)
  • Bharti Airtel
    1,892.00 1,422.30(%)
  • Garden Reach Sh.
    2,589.15 1,180.10(%)
  • Reliance Industr
    1,469.00 1,115.55(%)
  • Quality Power El
    931.85 890.00(%)
  • Bharat Dynamics
    1,675.35 897.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen
  • BSE Code : 2685.0
  • ISIN : INE083A01026
63.23 0 (-0.11%)
  • As on 18 Jul 2025 (EOD)

  • Today’s Low

    63.00

  • Today’s High

    65.12

  • Open

    63.50

  • Perv Close

    63.30

  • 52W Low

    42.00

  • 52W High

    100.90

Key Indicators

  • P/E(TTM)

    34.16

  • Mar.Cap (₹Cr.)

    3,464.71

  • Div & Yield %

    0.32

  • Book Value(₹)

    21.56

  • Debt-Equity Ratio

    -0.11

  • AGM Date

    17-Jul-2025

  • EPS

    1.85

  • P/E Ratio

    34.16

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,464.71

  • RONW (%)

    12.08

  • ROCE (%)

    16.12

Score Board

  • Equity (₹ in Cr.)

    109.59

  • BV (₹)

    21.60

  • Sales( ₹ in Cr.)

    1,554.54

  • NP (in Cr.)

    101.58

  • NP Var(%)

    -8.0

  • Div%

    10.0

  • CPS (₹)

    2.30

  • EPS (₹)

    1.90

  • Traded Value (₹ in Lakhs)

    3,463.07

  • 52 Week High

    100.90

  • 52 Week Low

    42.00

  • Price BSE

    63.0

  • Price NSE

    63.00

  • Market Capital( in Cr.)

    3,463.07

  • P/C Ratio

    27.40

  • P/E Ratio

    34.00

  • Price Vs.BV

    1.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Other Income 12.57 5.76 10.24 11.77 9.42 3.67
Stock Adjustments -5.13 -16.54 -1.74 41.98 7.58 19.46
Total Income 1,545.03 1,328.10 1,457.77 1,166.17 808.99 740.37
EXPENDITURE :            
Raw Materials 945.15 886.48 988.81 778.60 528.67 485.82
Power and Fuel Cost 34.09 23.78 18.93 13.00 12.56 13.18
Employee Cost 160.28 146.19 150.00 123.20 98.07 84.74
Other Manufacturing Expenses 44.19 33.81 23.39 13.57 10.54 9.47
Selling and Administration Expenses 163.47 111.62 87.90 82.36 73.37 67.36
Miscellaneous Expenses 23.47 43.19 49.36 31.30 11.89 11.11
Employee Benefit Expenses 160.28 146.19 150.00 123.20 98.07 84.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,370.64 1,245.08 1,318.39 1,042.03 735.10 671.68
Operating Profit 174.39 83.03 139.37 124.15 73.89 68.69
Interest 3.51 1.98 -7.37 1.79 1.97 2.07
Gross Profit 170.88 81.05 146.74 122.36 71.92 66.62
Depreciation 21.90 18.01 21.19 28.11 34.43 38.01
Profit Before Tax 148.98 63.04 125.55 94.25 37.49 28.61
Current Tax 38.48 16.60 22.00 0.00 5.15 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.20 2.48 0.00 0.00 0.00
Reported Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 217.27 171.03 74.96 -19.29 -51.62 -80.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 5.00 0.00 0.00 0.00
P & L Balance carried down 328.20 217.27 171.03 74.96 -19.29 -51.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.17 0.90 2.12 2.10 0.72 0.64
Earnings Per Share(Adj)-Unit Curr 2.17 0.90 2.12 2.10 0.72 0.64
Book Value 17.39 15.26 11.97 8.92 6.83 6.17
Book Value(Adj)-Unit Curr 17.39 15.26 11.97 8.92 6.83 6.17

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 154,129,838 28.13 154,129,838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,241,750 7.53 41,241,750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195,371,588 35.65 195,371,588 35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 60,000 0.01 60,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,090,298 0.56 3,090,298 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,446,706 1.72 9,446,706 38
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,143,530 0.94 5,143,530 4
Mutual Funds / UTI 13,803 0.00 13,803 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,754,337 3.24 17,754,337 49
2] Non Institution
Bodies Corporate 12,459,922 2.27 11,826,551 716
Clearing Members 794,645 0.15 794,645 63
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,258,814 1.32 7,257,157 3,233
Foreign Non Institution Other 38,533,120 7.03 38,533,120 3
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 32,364,984 5.91 27,547,089 110
Individuals holding nominal share capital up to Rs. 1 lakh 238,050,283 43.44 217,269,583 456,963
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 38,831 0.01 38,831 7
Others 0 0.00 0 0
Sub Total 334,827,774 61.11 308,594,151 461,096
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 547,953,699 100.00 521,720,076 461,180

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen Laboratories Ltd
  • BSE Code : 2685.0
  • ISIN : INE083A01026

  • Incorporation Year

    1984

  • Registered Office

    Morepen Village
    Nalagarh Road Near Baddi, Solan,
    Himachal Pradesh-173205

  • Telephone

    91-01795-276201-03

  • FAX

    91-01795-276204

  • Chairman

    Sushil Suri

  • Managing Director

    Sushil Suri

  • Company Secretary

    Vipul Kumar Srivatava

  • Auditor

    S P Babuta & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Morepen Labs. 63.20 1,550.16 1,537.59 34.16 17.08
Abbott India 34,128.35 6,097.18 5,848.91 51.27 44.71
Astrazeneca Phar 9,386.25 1,330.33 1,295.53 202.73 33.26
P & G Health Ltd 5,873.00 1,166.89 1,151.26 38.81 39.76
Glaxosmi. Pharma 3,170.15 3,866.05 3,723.49 58.44 58.72
Cipla 1,482.45 20,029.57 19,044.85 23.22 21.40
Amrutanjan Healt 700.30 437.58 421.23 39.84 20.84
Fermenta Biotec. 370.80 315.24 307.09 16.14 4.10
Guj. Themis Bio. 370.35 174.19 169.82 82.67 44.82
Bliss GVS Pharma 156.80 703.42 667.20 23.98 9.16
Ambalal Sarabhai 35.55 19.33 4.04 32.92 2.10